Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

Delayed Data
As of Dec 15
 +4.39 / +1.36%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 30 analysts offering 12-month price forecasts for Biogen have a median target of 354.50, with a high estimate of 430.00 and a low estimate of 279.00. The median estimate represents a +8.10% increase from the last price of 327.94.

Analyst Recommendations

The current consensus among 34 polled investment analysts is to Buy stock in Biogen. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Jan 31

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -12.19%
Growthannually 9.07%


Growthquarterly -0.53%
Growthannually 5.09%
Key to the earnings and sales forecast charts.